Clinical trial

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

NCT00330304 · University of Cape Town, Other · Completed

Key facts

NCT number NCT00330304
Title Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children
Official title Long Term Study of 2 Isoniazid (INH) Prophylactic Regimens With Concomitant Cotrimoxazole (CTX) in HIV-infected Children - Impact on Morbidity, Mortality, Bacterial Resistance and Incidence of Tuberculosis
Lead sponsor University of Cape Town, Other
Collaborators University of Stellenbosch Medical Research Council Rockefeller Foundation
Status Completed
Phase Phase 3
Study type Interventional
Conditions Tuberculosis
Intervention type Drug, Other
Interventions Isoniazid, Cotrimoxazole, isoniazid, placebo
Enrollment 450
Start date Jan 1, 2003
Primary completion Nov 15, 2011
Completion Nov 15, 2011
First posted May 26, 2006
Last update posted Apr 22, 2019
Countries South Africa

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies